ASP Isotopes (NASDAQ:ASPI - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.28) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by ($0.13), FiscalAI reports. The firm had revenue of $5.12 million for the quarter, compared to the consensus estimate of $5.68 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.
ASP Isotopes Stock Performance
Shares of ASPI stock traded down $0.20 during trading hours on Monday, reaching $1.54. The company had a trading volume of 4,475,844 shares, compared to its average volume of 4,713,274. The business has a fifty day moving average price of $2.57 and a 200-day moving average price of $4.59. ASP Isotopes has a one year low of $1.53 and a one year high of $8.60. The firm has a market cap of $236.10 million, a PE ratio of -1.17 and a beta of 3.77. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87.
Insider Activity at ASP Isotopes
In related news, CFO Heather Kiessling sold 21,830 shares of the firm's stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $2.19, for a total value of $47,807.70. Following the transaction, the chief financial officer owned 1,504,422 shares of the company's stock, valued at approximately $3,294,684.18. This trade represents a 1.43% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Robert Ainscow sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total transaction of $97,500.00. Following the sale, the chief operating officer owned 2,256,879 shares of the company's stock, valued at $8,801,828.10. This trade represents a 1.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 245,285 shares of company stock valued at $899,887 over the last ninety days. Company insiders own 14.40% of the company's stock.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the stock. Weiss Ratings reiterated a "sell (d-)" rating on shares of ASP Isotopes in a report on Monday, September 21st. Wall Street Zen raised shares of ASP Isotopes from a "strong sell" rating to a "sell" rating in a research report on Saturday, August 22nd. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $12.00.
View Our Latest Analysis on ASP Isotopes
About ASP Isotopes
(
Get Free Report)
ASP Isotopes Inc. is an advanced materials company focused on producing and commercializing enriched isotopes. Its proprietary Aerodynamic Separation Process is designed to separate isotopes and support production across a range of applications. The company's targeted products include isotopes used in medical imaging and pharmaceuticals, semiconductor manufacturing, quantum technologies and nuclear energy. Examples include molybdenum-100, silicon-28 and ytterbium-176. ASP Isotopes is headquartered in the United States and has pursued isotope-enrichment operations in South Africa.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ASP Isotopes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ASP Isotopes wasn't on the list.
While ASP Isotopes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.